# |
PMID |
Sentence |
1 |
20434554
|
Here we describe a highly versatile VLP platform for peptide display based on VLPs of the RNA bacteriophage PP7.
|
2 |
20434554
|
PP7 VLPs displaying the HPV16 L2 epitope generated robust anti-HPV16 L2 serum antibodies after intramuscular injection that protected mice from genital infection with HPV16 pseudovirus as well as a heterologous HPV pseudovirus type, HPV45.
|
3 |
20434554
|
Thus, PP7 VLPs are well-suited for the display of a wide diversity of peptides in a highly immunogenic format.
|
4 |
20434554
|
Here we describe a highly versatile VLP platform for peptide display based on VLPs of the RNA bacteriophage PP7.
|
5 |
20434554
|
PP7 VLPs displaying the HPV16 L2 epitope generated robust anti-HPV16 L2 serum antibodies after intramuscular injection that protected mice from genital infection with HPV16 pseudovirus as well as a heterologous HPV pseudovirus type, HPV45.
|
6 |
20434554
|
Thus, PP7 VLPs are well-suited for the display of a wide diversity of peptides in a highly immunogenic format.
|
7 |
20434554
|
Here we describe a highly versatile VLP platform for peptide display based on VLPs of the RNA bacteriophage PP7.
|
8 |
20434554
|
PP7 VLPs displaying the HPV16 L2 epitope generated robust anti-HPV16 L2 serum antibodies after intramuscular injection that protected mice from genital infection with HPV16 pseudovirus as well as a heterologous HPV pseudovirus type, HPV45.
|
9 |
20434554
|
Thus, PP7 VLPs are well-suited for the display of a wide diversity of peptides in a highly immunogenic format.
|
10 |
21549786
|
Using a mouse model for HPV infection, we show that intravaginal immunization with either HPV type 16 VLPs or with PP7 bacteriophage VLPs displaying a peptide derived from the HPV minor capsid protein L2 could protect mice from genital infection with an HPV16 pseudovirus.
|
11 |
21858066
|
A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2.
|